viernes, 22 de febrero de 2013

Valor predictivo de test 6 minutos marcha y BNP sobre mortalidad a los 2 años en pacientes con HP

Conclusions:  6MWD and BNP values at baseline or week 12 identified a population with an elevated risk of death at 2 years. A repeat assessment of 6MWD or BNP after 12 weeks of ambrisentan therapy did not provide additional prognostic information beyond that obtained from baseline values.
En Chest

No hay comentarios: